Dato’ Dr. Mohd Ibrahim A. Wahid Medical Oncologist

Consultant - Medical Oncologist , Experience:

Book Appointment

About Doctor

Dato’ Dr. Mohd Ibrahim A. Wahid is among the top oncologist in Kuala Lumpur, Malaysia.

Dato’ Dr Mohamed Ibrahim A. Wahid received his Bachelor of Medicine, Bachelor of Surgery (MBBCh) degree from the University of Wales, College of Medicine and his postgraduat specialist degree from the Royal College of Radiologists in London, United Kingdom (UK).

After being trained in the UK, he returned to Malaysia and set up the Cancer Unit at the University of Malaya Medical Centre (UMMC) where he was appointed as the Head of Clinical Oncology before joining Pantai Hospital Kuala Lumpur.

In 2010, Dr Mohamed Ibrahim was appointed as the President of the Malaysian Oncological Society (MOS) and became President of the Asia Pacific Federation of Cancer Congress (APFOCC) in 2011. He was also the President of the South East Asia Radiology Oncology Group (SEAROG) from 2011 to 2013 and a Regent for South East Asia’s International Association for the Study of Lung Cancer (IASLC). Dr Mohamed Ibrahim currently serves as the Vice President (Oncology) for the College of Radiology, Malaysia.

His fields of interest include lung, breast, head and neck, urological and gastro intestinal tumour. Apart from his role as a stereotactic radiotherapy & SBRT specialist, Dr Mohamed Ibrahim pioneered the development of high technology radiotherapy treatment in Malaysia.

Dr Mohamed Ibrahim has contributed to over 50 journals and publications, and is a speaker at local and international oncology conferences, public and media forums as well as health programmes in Malaysia and SEA.


Pantai Hospital, Kuala Lumpur, Malaysia


  • All Solid Tumours ( Adult Only)

Procedures Performed

  • Stereotactic Radiosurgery, SBRT ( Stereotactic Body Radiotherapy)

Research & Publications

1) Radiotherapy- Patient guidelines to Radiation therapy

1) Jeevendra Kanagalingam, Mohamed Ibrahim A.Wahid, Jin-Ching Lin,Nonette A.Cupino, Edward Liu, Jin-Hyoung Kang, Shouki Bazarbashi, Nicole Bender Moreira, Harsha Arumugam, Stefan Mueller, HanlimMoon. Patient and oncologist perception regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion(ADOPT) study in Supportive Care in Cancer, https://doi.org/10.1007/s00520-018-4050-3, Published online : 31 January 2018

2) Weng Heng Tang, Adlinda Alip, Marniza Saad, Vincent Chee EE Phua, Hari Chandran, Yi Hang Tan, Yan Yin Tan, Voon Fong Kua, Mohamed Ibrahim Wahid, Lye Mun Tho. Prognostic Factors in Patient with Non-small Cell Lung Carcinoma and Brain Metastases, a Malaysian Perspective in Asian Pacific journal of cancer prevention: APJCP01/2015:16(5) :1901-6

3) Gerald Cc Lim, Emran N Aina, Soon K Cheah, Fuad Ismail, Gwo F Ho, Lye M Tho, Cheng H Yip, Nur A Taib, Kwang J Chong, Jayendran Dharmaratnam, Matin M Abdullah, Ahmad K Mohamed, Kean F Ho, Kananathan Ratnavelu, Kananathan M Lim, Kin W Leong, Ibrahim A Wahid, Teck O Lim. Closing the global cancer divide-performance of breast cancer care services in a middle income developing country. BMC Cancer 03/2014:14(1):212.DOI:10.1186/1471-2407-14-212

4)  A D’cruz, T Lin, A.K.Anand,D Atmakusuma,M J Calaguas, I Chitapanarux, B C Cho, B.C Goh,Y Guo,W S Hsieh, J C Lin, P J Lou, T Lu, K Prabhash, V Sriuranpong, P Tang, V V Vu, I Wahid, K K Ang, A T Chan. Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines in Oral Oncology 07/2013: 49(9).DOI:10.1016/j.oraloncology.2013.05.010

5) Chong-Kin Liam, Mohamed Ibrahim A. Wahid, Pathmanathan Rajadurai, Yoke Queen Cheah, Tiffany Shi Yeen. Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients in Journal of Thoracic Oncology, Volume 8, Number 6, June 2013

6) G.C.C.Lim,N.A.Emran,G.W.Ho.C.H.Yip,K.J.Chong,M.M.Abdullah,A.K.Mohamed,Y.C. Foo, K.F.Ho, R.Kananathan, K.W.Leong, I.A.Wahid,T.O.Lim. AOSOP1 closing the cancer divide : Performance of breast cancer care services in Malaysia, A Middle –Income Developing Country in European Journal of Cancer 03/2013,; 49:S1. DOI: 10.1016/S0959-8049(13) 00171-8

7) Norie Kawahara, Haruhiko Sugimura, Akira Nakagawara, Tohru Masui, Jun Miyake, Masanori Akiyama, Ibrahim A Wahid, Xishan Hao, Hideyuki Akaza. The 6th Asia Cancer Forum, what should we do to place cancer on the global health agenda? Sharing information leads to human security. Japanese Journal of Clinical Oncology 03/2011, 41 (5): 723-9. DOI : 10.1093

8)  Seiji Naito,Yoshihiko Tomita, Sun Young Rha, Hirotsugu Uemura, Mototsugu Oya, He Zhi Song, Li Han Zhong and Mohamed Ibrahim Bin A Wahid. Kidney Cancer Working Group Report in Japanese Journal of Clinical Oncology (JJCO) Jpn j Clin Oncol 2010:40 (supplement)i5l-i56

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy